- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
DigiPath Labs to Evaluate Orange Photonics' Lightlab Marijuana Potency Analyzer
DigiPath (OTCBB:DIGP) announced that its subsidiary has been picked by Orange Photonics to evaluate its LightLab Marijuana Potency Analyzer. As quoted in the press release: The LightLab Analyzer is a portable photonics based instrument that provides an instant analysis of THC-A, delta-9 THC, CBD-A and CBD potency levels present in cannabis samples. “There is an emerging market for …
DigiPath (OTCBB:DIGP) announced that its subsidiary has been picked by Orange Photonics to evaluate its LightLab Marijuana Potency Analyzer.
As quoted in the press release:
The LightLab Analyzer is a portable photonics based instrument that provides an instant analysis of THC-A, delta-9 THC, CBD-A and CBD potency levels present in cannabis samples.
“There is an emerging market for rapid potency analytics outside of certified cannabis testing labs,” says DigiPath Labs Chief Science Officer, Cindy Orser, “these instruments are designed to be rugged, portable and accurate for the four cannabinoids: THCA, delta-9 THC, CBDA and CBD.”
DigiPath Labs will systematically collect comparative cannabinoid data from 100 cannabis flower samples using both the LightLab Analyzer and its own state-of-the art testing laboratory. This dataset will enable Orange Photonics to validate its calibration software and provide it with needed data for the marketing of its new LightLab device.
“We are excited to be working with DigiPath Labs in Las Vegas to help validate the LightLab Marijuana Potency Analyzer. We chose to work with Digipath because of their mission-driven commitment to consistent, accurate testing options and standards for the industry,” says Dylan Wilks, CEO/CTO of Orange Photonics. “Third party validation is essential for us to ensure the LightLab provides the level of performance the industry wants.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.